3651 results for «237»
3651 results
Challenging PCI on bifurcation lesions
22 May 2026 – From EuroPCR 2026
Addressing the complexities of PCI in bifurcation lesions, this session highlights novel techniques such as the TAP and modified mini-crush methods, alongside strategies for managing challenging coronary anatomy. Validation of novel approaches like POT-side DCB-POT for left main bifurcations is also featured.
Asymptomatic high-risk patients: can CT coronary angiography improve our practice?
21 May 2026 – From EuroPCR 2026
This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...
When a primary PCI goes wrong
19 May 2026 – From EuroPCR 2026
This session investigates complications encountered during primary percutaneous coronary interventions (PCI). It covers management of no-reflow phenomena, innovative guide extension catheter aspiration techniques for thrombus-rich STEMI, challenges when balloon crossing fails, vein graft PCI pitfalls, and complex concurrent ischemic events involving myocardial infarction and limb ischemia....
Aortic stenosis: from diagnostic to treatment
21 May 2026 – From EuroPCR 2026
This session provides an in-depth review of contemporary management of aortic stenosis, covering diagnostic advancements, temporal trends, and treatment outcomes. It includes insights from the LAPLACE-TAVI registry focusing on low-risk patients, discusses the growing feasibility of day-case TAVI procedures, compares transcatheter and surgical valve replacements in...
How should I treat my CTO? Adapting to local conditions
22 May 2026 – From EuroPCR 2026
This session delves into managing chronic total occlusions (CTO) under resource-limited conditions, highlighting the essential CTO toolbox and strategic procedural planning. It emphasizes that an antegrade-first approach, often with dual arterial access, can achieve high success in many CTO cases, illustrated through complex real-world cases from...
Complex PCI - Best cases from PCR Global Interventional Academy - Part 2
21 May 2026 – From EuroPCR 2026
This session showcases best cases from the PCR Global Interventional Academy focusing on complex PCI scenarios. It addresses challenges such as managing ostial left anterior descending artery lesions, strategies for branch protection, implications of coronary involvement during TAVI, and future directions in complex coronary interventions. The...
AsiaPCR/SingLIVE 2017: closing Ceremony and Awards
21 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....
Chairperson
Chairperson
AsiaPCR/SingLIVE 2017: Opening Ceremony
19 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.
Chairperson
Successful Stent-less Percutaneous Coronary Intervention of Chronic Total Occlusion by Ablation Devices in a Young Adult
04 Nov 2021
View this case with a 38-year-old male with effort angina and chronic total occlusion at the ostial segment of the left anterior descending artery.
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure
06 Nov 2021
TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.
Author
The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction
18 Nov 2024
Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.
Author
